Form 4 for GUTS FRACTYL HEALTH, INC.
Accepted 2024-09-13 00:00:00 ET · period of report 2024-09-12 · accession 0000950170-24-106530 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-09-13 | 2024-09-12 | GUTS | Caplan Jay David | Pres, Chief Product Off | M - OptEx | $1.70 | +95.5K | 95.5K | New | +$162.3K |
| D | 2024-09-13 | 2024-09-12 | GUTS | Caplan Jay David | Pres, Chief Product Off | S - Sale+OE | $2.90 | -65.0K | 30.5K | -68% | -$188.5K |
| D | 2024-09-13 | 2024-09-12 | GUTS | Caplan Jay David | Pres, Chief Product Off | M - OptEx | $0.00 | -95.5K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-12 | M | A | 95,484 | $1.70 | 95,484 | D | — | — | |
| 2 | Common | Common Stock | 2024-09-12 | S | D | 65,000 | $2.90 | 30,484 | D | — | — | (F1) The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $2.85 to $3.06. The Reporting Person undertakes to provide upon request the Staff of the Securities and Exchange Commission, the Issuer, or any stockholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote. |
| 3 | Derivative | Stock Option | 2024-09-12 | M | D | 95,484 | $0.00 | 0 | D | $1.70 · — to 2024-11-10 | 95,484 Common Stock | (F2) The option is fully vested and exercisable. |